Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
52 week high
|
Strong Performer, Getting Expensive
2292.2000
42.00
(
1.87
%)
NSE
Feb 25, 2026
15:31 PM
New 52W High today
Volume:
1.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
13 Feb 2025
US FDA Approval
52 week high
2292.20
1.87%
LUPIN LTD
Buy:
Lupin Ltd.
by
Prabhudas Lilladhar
Target: 2420
Recommendation
Target
Prabhudas Lilladhar
Lupin Ltd. is trading above all available SMAs
More from Lupin Ltd.
Recommended
Market closes higher, supported by a rebound in IT stocks & positive global cues
Trendlyne Marketwatch |
25 Feb 2026, 03:57PM
Five stocks to buy from analysts this week - February 24, 2026
The Baseline |
24 Feb 2026, 06:01PM
Lupin expects normalization by September quarter
|
17 Apr 2020